{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:28:19Z","timestamp":1772666899575,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Tianjin Science and Technology Bureau","award":["No. 21JCZDJC01050"],"award-info":[{"award-number":["No. 21JCZDJC01050"]}]},{"name":"the Key Research Project of Tianjin Health Commission","award":["No.TJWJ2021ZD003"],"award-info":[{"award-number":["No.TJWJ2021ZD003"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["No.TJYXZDXK-047A"],"award-info":[{"award-number":["No.TJYXZDXK-047A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15237-y","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:35:25Z","timestamp":1763138125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of extracellular vesicle-derived lncRNAs during the progression of HBV-related hepatocellular carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiandong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingtang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"1","key":"15237_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11427-023-2423-1","volume":"67","author":"S He","year":"2024","unstructured":"He S, Xia C, Li H, Cao M, Yang F, Yan X, et al. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors. Sci China Life Sci. 2024;67(1):122\u201331. https:\/\/doi.org\/10.1007\/s11427-023-2423-1.","journal-title":"Sci China Life Sci"},{"issue":"5","key":"15237_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.12449\/JCH240508","volume":"40","author":"National Health Commission of the People\u2019s Republic of China","year":"2024","unstructured":"National Health Commission of the People\u2019s Republic of China. Standard for diagnosis and treatment of primary liver cancer(2024 edition). J Clin Hepatol. 2024;40(5):893\u2013918. https:\/\/doi.org\/10.12449\/JCH240508.","journal-title":"J Clin Hepatol"},{"issue":"1","key":"15237_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-024-00500-6","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. NAT REV DIS PRIMERS. 2021;7(1):6. https:\/\/doi.org\/10.1038\/s41572-024-00500-6.","journal-title":"NAT REV DIS PRIMERS"},{"issue":"4","key":"15237_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jcmgh.2023.01.001","volume":"15","author":"SH Yeh","year":"2023","unstructured":"Yeh SH, Li CL, Lin YY, Ho MC, Wang YC, Tseng ST, et al. Hepatitis B virus DNA integration drives carcinogenesis and provides a new biomarker for HBV-related HCC. Cell Mol Gastroenterol Hepatol. 2023;15(4):921\u20139. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.01.001.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"15237_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1874357901812010026","volume":"12","author":"A Petruzziello","year":"2018","unstructured":"Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol J. 2018;12:26\u201332. https:\/\/doi.org\/10.2174\/1874357901812010026.","journal-title":"Open Virol J"},{"issue":"5","key":"15237_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23200","volume":"34","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Wang S, Jin J, Ying S, Chen Z, Zhu D, et al. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases. J Clin Lab Anal. 2020;34(5):e23200. https:\/\/doi.org\/10.1002\/jcla.23200.","journal-title":"J Clin Lab Anal"},{"key":"15237_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v14050986","author":"G Rizzo","year":"2022","unstructured":"Rizzo G, Cabibbo G, Craxi A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14050986.","journal-title":"Viruses"},{"issue":"1","key":"15237_CR8","first-page":"6","volume":"32","author":"JB Xuan","year":"2024","unstructured":"Xuan JB, Wang K. Diagnosis and treatment management of hepatic adenoma. J Hepatobiliary Surg. 2024;32(1):6\u20139. doi:CNKI:SUN:GDWZ.0.2024-01-003.","journal-title":"J Hepatobiliary Surg"},{"key":"15237_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3544","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371:m3544. https:\/\/doi.org\/10.1136\/bmj.m3544.","journal-title":"BMJ"},{"key":"15237_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071852","author":"MA Omar","year":"2023","unstructured":"Omar MA, Omran MM, Farid K, Tabll AA, Shahein YE, Emran TM, et al. Biomarkers for hepatocellular carcinoma: from origin to clinical diagnosis. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11071852.","journal-title":"Biomedicines"},{"issue":"2","key":"15237_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, et al. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022;28(2):216\u201329. https:\/\/doi.org\/10.3748\/wjg.v28.i2.216.","journal-title":"World J Gastroenterol"},{"key":"15237_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/bs.acc.2017.10.003","volume":"83","author":"M Macias","year":"2018","unstructured":"Macias M, Alegre E, Diaz-Lagares A, Patino A, Perez-Gracia JL, Sanmamed M, Lopez-Lopez R, Varo N, Gonzalez A. Liquid biopsy: from basic research to clinical practice. ADV CLIN CHEM. 2018;83:73\u2013119. https:\/\/doi.org\/10.1016\/bs.acc.2017.10.003.","journal-title":"ADV CLIN CHEM"},{"key":"15237_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091226","author":"MP Driga","year":"2021","unstructured":"Driga MP, Catalin B, Olaru DG, Slowik A, Plesnila N, Hermann DM, et al. The need for new biomarkers to assist with stroke prevention and prediction of post-stroke therapy based on plasma-derived extracellular vesicles. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9091226.","journal-title":"Biomedicines"},{"issue":"6788","key":"15237_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/35015701","volume":"405","author":"DJ Lockhart","year":"2000","unstructured":"Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature. 2000;405(6788):827\u201336. https:\/\/doi.org\/10.1038\/35015701.","journal-title":"Nature"},{"issue":"23","key":"15237_CR15","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1158\/0008-5472.CAN-24-0832","volume":"84","author":"PP Hou","year":"2024","unstructured":"Hou PP, Zheng CM, Wu SH, Liu XX, Xiang GX, Cai WY, et al. Extracellular vesicle-packaged ACSL4 induces hepatocyte senescence to promote hepatocellular carcinoma progression. Cancer Res. 2024;84(23):3953\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0832.","journal-title":"Cancer Res"},{"key":"15237_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2025.117228","volume":"276","author":"K Yi","year":"2025","unstructured":"Yi K, Zhang Z, Chen P, Xi X, Zhao X, Rong Y, et al. Tidal microfluidic chip-based isolation and transcriptomic profiling of plasma extracellular vesicles for clinical monitoring of high-risk patients with hepatocellular carcinoma-associated precursors. Biosens Bioelectron. 2025;276:117228. https:\/\/doi.org\/10.1016\/j.bios.2025.117228.","journal-title":"Biosens Bioelectron"},{"issue":"3","key":"15237_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024;25(3):211\u201332. https:\/\/doi.org\/10.1038\/s41576-023-00662-1.","journal-title":"Nat Rev Genet"},{"key":"15237_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121751","volume":"325","author":"S Verma","year":"2023","unstructured":"Verma S, Sahu BD, Mugale MN. Role of lncrnas in hepatocellular carcinoma. Life Sci. 2023;325:121751. https:\/\/doi.org\/10.1016\/j.lfs.2023.121751.","journal-title":"Life Sci"},{"issue":"1","key":"15237_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57367-8","volume":"16","author":"Y Gao","year":"2025","unstructured":"Gao Y, Zhang Z, Huang X, You M, Du C, Li N, et al. HBV-associated hepatocellular carcinomas inhibit antitumor CD8(+) T cell via the long noncoding RNA HDAC2-AS2. Nat Commun. 2025;16(1):2055. https:\/\/doi.org\/10.1038\/s41467-025-57367-8.","journal-title":"Nat Commun"},{"issue":"4","key":"15237_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.dld.2021.01.003","volume":"53","author":"Y Yang","year":"2021","unstructured":"Yang Y, Mao F, Guo L, Shi J, Wu M, Cheng S, et al. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP. Dig Liver Dis. 2021;53(4):474\u201385. https:\/\/doi.org\/10.1016\/j.dld.2021.01.003.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"15237_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101716","volume":"5","author":"B Li","year":"2024","unstructured":"Li B, Hao K, Li M, Wang A, Tang H, Xu L, et al. Five miRNAs identified in fucosylated extracellular vesicles as non-invasive diagnostic signatures for hepatocellular carcinoma. Cell Rep Med. 2024;5(9):101716. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101716.","journal-title":"Cell Rep Med"},{"issue":"6","key":"15237_CR22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.14218\/JCTH.2023.00320","volume":"11","author":"H You","year":"2023","unstructured":"You H, Wang F, Li T, Xu X, Sun Y, Nan Y, Wang G, Hou J, Duan Z, Wei L, et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J CLIN TRANSL HEPATO. 2023;11(6):1425\u201342. https:\/\/doi.org\/10.14218\/JCTH.2023.00320.","journal-title":"J CLIN TRANSL HEPATO"},{"issue":"7","key":"15237_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","volume":"56","author":"H Yoshiji","year":"2021","unstructured":"Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. J Gastroenterol. 2021;56(7):593\u2013619. https:\/\/doi.org\/10.1007\/s00535-021-01788-x.","journal-title":"J Gastroenterol"},{"issue":"5","key":"15237_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000530495","volume":"12","author":"J Zhou","year":"2023","unstructured":"Zhou J, Sun H, Wang Z, Cong W, Zeng M, Zhou W, et al. Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition). Liver Cancer. 2023;12(5):405\u201344. https:\/\/doi.org\/10.1159\/000530495.","journal-title":"Liver Cancer"},{"issue":"2","key":"15237_CR25","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12451","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan D, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks T, Erdbrugger U, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J EXTRACELL VESICLES. 2024;13(2):e12404. https:\/\/doi.org\/10.1002\/jev2.12451.","journal-title":"J EXTRACELL VESICLES"},{"issue":"Web Server issu","key":"15237_CR26","doi-asserted-by":"publisher","first-page":"W345","DOI":"10.1093\/nar\/gkm391","volume":"35","author":"L Kong","year":"2007","unstructured":"Kong L, Zhang Y, Ye ZQ, Liu XQ, Zhao SQ, Wei L, et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res. 2007;35(Web Server issue):W345\u20139. https:\/\/doi.org\/10.1093\/nar\/gkm391.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"15237_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt646","volume":"41","author":"L Sun","year":"2013","unstructured":"Sun L, Luo H, Bu D, Zhao G, Yu K, Zhang C, et al. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res. 2013;41(17):e166. https:\/\/doi.org\/10.1093\/nar\/gkt646.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"15237_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt006","volume":"41","author":"L Wang","year":"2013","unstructured":"Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Li W. Cpat: coding-potential assessment tool using an alignment-free logistic regression model. Nucleic Acids Res. 2013;41(6):e74. https:\/\/doi.org\/10.1093\/nar\/gkt006.","journal-title":"Nucleic Acids Res"},{"key":"15237_CR29","doi-asserted-by":"publisher","unstructured":"Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, Heger A, Hetherington K, Holm L, Mistry J et al. Pfam: the protein families database. NUCLEIC ACIDS RES : 2014, 42(Database issue):D222-D230. https:\/\/doi.org\/10.1093\/nar\/gkt1223","DOI":"10.1093\/nar\/gkt1223"},{"issue":"1","key":"15237_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedlander","year":"2012","unstructured":"Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N. MiRdeep2 accurately identifies known and hundreds of novel microrna genes in seven animal clades. Nucleic Acids Res. 2012;40(1):37\u201352. https:\/\/doi.org\/10.1093\/nar\/gkr688.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15237_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01685-8","volume":"22","author":"K Miyazaki","year":"2023","unstructured":"Miyazaki K, Wada Y, Okuno K, Murano T, Morine Y, Ikemoto T, et al. An exosome-based liquid biopsy signature for pre-operative identification of lymph node metastasis in patients with pathological high-risk T1 colorectal cancer. MOL CANCER. 2023;22(1):2. https:\/\/doi.org\/10.1186\/s12943-022-01685-8.","journal-title":"MOL CANCER"},{"issue":"1","key":"15237_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37403-1","volume":"14","author":"H Shin","year":"2023","unstructured":"Shin H, Choi BH, Shim O, Kim J, Park Y, Cho SK, et al. Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers. NAT COMMUN. 2023;14(1):1644. https:\/\/doi.org\/10.1038\/s41467-023-37403-1.","journal-title":"NAT COMMUN"},{"key":"15237_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01302-y","volume":"20","author":"XH Sun","year":"2020","unstructured":"Sun XH, Wang YT, Li GF, Zhang N, Fan L. Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma. CANCER CELL INT. 2020;20:226. https:\/\/doi.org\/10.1186\/s12935-020-01302-y.","journal-title":"CANCER CELL INT"},{"issue":"3","key":"15237_CR34","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/cas.14807","volume":"112","author":"Y Yokota","year":"2021","unstructured":"Yokota Y, Noda T, Okumura Y, Kobayashi S, Iwagami Y, Yamada D, et al. Serum exosomal miR\u2010638 is a prognostic marker of HCC via downregulation of VE\u2010cadherin and ZO\u20101 of endothelial cells. Cancer Sci. 2021;112(3):1275\u201388. https:\/\/doi.org\/10.1111\/cas.14807.","journal-title":"Cancer Sci"},{"issue":"6","key":"15237_CR35","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.dld.2025.03.022","volume":"57","author":"T Liu","year":"2025","unstructured":"Liu T, Cui Y, Ouyang Y, Wang M, Yue S. Exosomal CCT3 as a biomarker for diagnosis and immune therapy response in patients diagnosed with hepatocellular carcinoma. DIGEST LIVER DIS. 2025;57(6):1315\u201324. https:\/\/doi.org\/10.1016\/j.dld.2025.03.022.","journal-title":"DIGEST LIVER DIS"},{"issue":"2","key":"15237_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108834","volume":"27","author":"R Peng","year":"2024","unstructured":"Peng R, Zuo S, Li X, Huang Y, Chen S, Zou X, et al. Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics. iScience. 2024;27(2):108834. https:\/\/doi.org\/10.1016\/j.isci.2024.108834.","journal-title":"iScience"},{"issue":"1","key":"15237_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05651-4","volume":"22","author":"Z Li","year":"2024","unstructured":"Li Z, Li J, Li F, Han L, Sui C, Zhou L, et al. Potential functions and mechanisms of lysine crotonylation modification (Kcr) in tumorigenesis and lymphatic metastasis of papillary thyroid cancer (PTC). J Transl Med. 2024;22(1):874. https:\/\/doi.org\/10.1186\/s12967-024-05651-4.","journal-title":"J Transl Med"},{"issue":"1","key":"15237_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05513-1","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ying Y, Wang M, Ma C, Jia M, Shi L, et al. A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell Death Dis. 2023;14(1):8. https:\/\/doi.org\/10.1038\/s41419-022-05513-1.","journal-title":"Cell Death Dis"},{"issue":"6","key":"15237_CR39","doi-asserted-by":"publisher","first-page":"e22937","DOI":"10.1096\/fj.202202148RR","volume":"37","author":"L Tan","year":"2023","unstructured":"Tan L, Xiong D, Zhang H, Xiao S, Yi R, Wu J. ETS2 promotes cardiomyocyte apoptosis and autophagy in heart failure by regulating LncRNA TUG1\/miR-129-5p\/ATG7 axis. FASEB J. 2023;37(6):e22937. https:\/\/doi.org\/10.1096\/fj.202202148RR.","journal-title":"FASEB J"},{"issue":"8016","key":"15237_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-024-07501-1","volume":"630","author":"CT Stankey","year":"2024","unstructured":"Stankey CT, Bourges C, Haag LM, Turner-Stokes T, Piedade AP, Palmer-Jones C, Papa I, Silva DSM, Zhang Q, Cameron AJ, et al. A disease-associated gene desert directs macrophage inflammation through ETS2. NATURE. 2024;630(8016):447\u201356. https:\/\/doi.org\/10.1038\/s41586-024-07501-1.","journal-title":"NATURE"},{"issue":"4","key":"15237_CR41","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3390\/cimb46040198","volume":"46","author":"CG Fenton","year":"2024","unstructured":"Fenton CG, Ray MK, Paulssen RH. Challenges in defining a reference set of differentially expressed LncRNAs in ulcerative colitis by meta-analysis. Curr Issues Mol Biol. 2024;46(4):3164\u201374. https:\/\/doi.org\/10.3390\/cimb46040198.","journal-title":"Curr Issues Mol Biol"},{"key":"15237_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144975","volume":"758","author":"ZM Oo","year":"2020","unstructured":"Oo ZM, Adlat S, Sah RK, Myint M, Hayel F, Chen Y, et al. Brain transcriptome study through CRISPR\/Cas9 mediated mouse Dip2c gene knock-out. Gene. 2020;758:144975. https:\/\/doi.org\/10.1016\/j.gene.2020.144975.","journal-title":"Gene"},{"issue":"6","key":"15237_CR43","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/abbs\/gmab040","volume":"53","author":"W Wang","year":"2021","unstructured":"Wang W, Xu S, Di Y, Zhang Z, Li Q, Guo K, et al. Novel role of LINC01013\/miR-6795-5p\/FMNL3 axis in the regulation of hepatocellular carcinoma stem cell features. ACTA BIOCH BIOPH SIN. 2021;53(6):652\u201362. https:\/\/doi.org\/10.1093\/abbs\/gmab040.","journal-title":"ACTA BIOCH BIOPH SIN"},{"issue":"Suppl8","key":"15237_CR44","doi-asserted-by":"publisher","first-page":"viii16","DOI":"10.1093\/annonc\/mdz384","volume":"30","author":"JP Solomon","year":"2019","unstructured":"Solomon JP, Benayed R, Hechtman JF, Ladanyi M. Identifying patients with NTRK fusion cancer. ANN ONCOL. 2019;30(Suppl8):viii16\u201322. https:\/\/doi.org\/10.1093\/annonc\/mdz384.","journal-title":"ANN ONCOL"},{"issue":"4","key":"15237_CR45","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3892\/etm.2016.3599","volume":"12","author":"J Liu","year":"2016","unstructured":"Liu J, Hua P, Zhang LL, Hu Z, Zhu YW. Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy. EXP THER MED. 2016;12(4):2109\u201319. https:\/\/doi.org\/10.3892\/etm.2016.3599.","journal-title":"EXP THER MED"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15237-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:04:05Z","timestamp":1763172245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15237-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15237"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15237-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Nankai University Affiliated Third Center Hospital (Approval No. SZX-IRB2024-014-01). All procedures complied with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1768"}}